Sort
4,870 grants matching “glp 1”
NEUROPEPTIDE Y--EFFECTS ON ENERGY METABOLISM
$159,884University Of Minnesota Twin Cities · R01 · FY2000 · DK
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
$159,459Chee W Chia · National Institute On Aging · ZIA · FY2022 · AG
Core 2: Biospecimen
$158,922Elisa De Stanchina · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
The Comparative Effectiveness and Safety of Second-line Therapy in Patients with Type 2 Diabetes
$158,508Jung-Im Shin · Johns Hopkins University · K01 · FY2019 · DK
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
$158,161Paule Joseph · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Luminex High-Throughput Analysis Core
$157,824Jonathan Kurtis · University Of Rhode Island · P20 · FY2013 · GM
Nanoconjugate based on polymalic acid for brain tumor treatment
$157,231Julia Y Ljubimova · Cedars-Sinai Medical Center · U01 · FY2011 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment
$157,231Julia Y Ljubimova · Cedars-Sinai Medical Center · U01 · FY2012 · CA
Pre-Clinical Vector Production Core
$157,020William F. Goins · Brigham And Women'S Hospital · P01 · FY2022 · CA
Micellar Daunorubicin for the Treatment of Bone Cancer
$156,868Kevin N Sill · Intezyne Technologies, Llc · U43 · FY2014 · CA
fMRI and Ghrelin in Obesity and Binge Eating Disorder
$156,719Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R03 · FY2007 · DK
GLP1R neurons in the subfornical organ and integration of thirst and satiety cues
$156,568Rui Chang · Yale University · K01 · FY2019 · DK
GLP1R neurons in the subfornical organ and integration of thirst and satiety cues
$156,568Rui Chang · Yale University · K01 · FY2020 · DK
GLP1R neurons in the subfornical organ and integration of thirst and satiety cues
$156,568Rui Chang · Yale University · K01 · FY2018 · DK
Alleviating carbohydrate counting in adults with type 1 diabetes with weekly Semaglutide injections added to an automated insulin delivery with LyumjevÂ
$156,218Michael Tsoukas · Mcgill University Health Ctr Res Inst · R01 · FY2024 · DK
Pre-Clinical Vector Production Core
$155,559William F. Goins · Brigham And Women'S Hospital · P01 · FY2021 · CA
Toward optimizing diabetes care in persons with chronic kidney disease
$155,541Jinnie J. Rhee · Stanford University · K01 · FY2017 · DK
Examining the role of locus coeruleus glucagon-like peptide-1 receptors in feeding behavior
$155,346Samantha Fortin · University Of Pennsylvania · K01 · FY2023 · DK
PTPRD phosphatase inhibitors for stimulant use disorders
$155,345George R Uhl · University Of Maryland Baltimore · UG3 · FY2024 · DA
A Novel Class of Lipids as Potential Therapeutic Agents to Promote Pancreatic Beta cell Survival and Prevent Type 1 Diabetes.
$155,249Ismail Syed · Beth Israel Deaconess Medical Center · K01 · FY2018 · DK
Diabetic Retinal Neurodegeneration in Youth Onset Diabetes
$155,000Risa Michelle Wolf · Johns Hopkins University · R21 · FY2025 · EY
Methocinnamox (MCAM): A novel opioid receptor antagonist
$154,967Charles P France · University Of Texas Hlth Science Center · UH3 · FY2023 · DA
The Comparative Effectiveness and Safety of Second-line Therapy in Patients with Type 2 Diabetes
$154,894Jung-Im Shin · Johns Hopkins University · K01 · FY2020 · DK
Toward optimizing diabetes care in persons with chronic kidney disease
$154,040Jinnie J. Rhee · Stanford University · K01 · FY2021 · DK
Toward optimizing diabetes care in persons with chronic kidney disease
$154,040Jinnie J. Rhee · Stanford University · K01 · FY2018 · DK